Health TrialsbyHealthPanel

HER2-Negative Advanced Breast Cancer

1

Review clinical trials related to HER2-Negative Advanced Breast Cancer. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Study of HB1801 Versus Docetaxel (Taxotere®) in Patients With Advanced Breast Cancer

This is a randomized, open-label, multicenter Phase Ⅲ clinical trial designed to evaluate the efficacy and safety of HB1801 versus Taxotere® in patients with HER2-negative advanced breast cancer.

Participants needed: 430
Trial details
Phase: Phase 3Age: 18-75Biological sex: AllType: InterventionalSponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Updated: Sep 4, 2026
Eligibility criteria

1. Age: 18-75 years (Whichever is on the day of signing the informed consent for... [+7]

1. Has received prior taxane-containing single-agent or combination regimens, an... [+17]

Read more